Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 CLNN stock ended at $0.390. This is 0.383% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 6.14% from a day low at $0.370 to a day high of $0.393.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Clene Inc. prices

Date Open High Low Close Volume
Apr 03, 2024 $0.400 $0.410 $0.380 $0.407 542 111
Apr 02, 2024 $0.428 $0.430 $0.388 $0.396 416 262
Apr 01, 2024 $0.431 $0.431 $0.405 $0.420 286 404
Mar 28, 2024 $0.430 $0.431 $0.420 $0.425 236 940
Mar 27, 2024 $0.420 $0.430 $0.410 $0.425 265 227
Mar 26, 2024 $0.425 $0.439 $0.415 $0.424 211 027
Mar 25, 2024 $0.430 $0.450 $0.412 $0.430 276 620
Mar 22, 2024 $0.431 $0.447 $0.422 $0.444 306 235
Mar 21, 2024 $0.410 $0.430 $0.401 $0.425 332 482
Mar 20, 2024 $0.401 $0.403 $0.393 $0.400 435 617
Mar 19, 2024 $0.394 $0.410 $0.390 $0.401 192 470
Mar 18, 2024 $0.400 $0.410 $0.380 $0.407 637 076
Mar 15, 2024 $0.404 $0.425 $0.392 $0.400 557 418
Mar 14, 2024 $0.440 $0.454 $0.395 $0.420 486 679
Mar 13, 2024 $0.488 $0.488 $0.430 $0.440 310 844
Mar 12, 2024 $0.470 $0.470 $0.423 $0.444 305 464
Mar 11, 2024 $0.500 $0.510 $0.422 $0.445 1 198 101
Mar 08, 2024 $0.410 $0.520 $0.400 $0.500 1 892 601
Mar 07, 2024 $0.409 $0.419 $0.392 $0.407 370 725
Mar 06, 2024 $0.375 $0.397 $0.375 $0.395 524 264
Mar 05, 2024 $0.390 $0.400 $0.365 $0.377 589 516
Mar 04, 2024 $0.382 $0.400 $0.366 $0.385 678 069
Mar 01, 2024 $0.420 $0.425 $0.375 $0.389 1 357 211
Feb 29, 2024 $0.440 $0.450 $0.397 $0.402 1 721 146
Feb 28, 2024 $0.426 $0.440 $0.406 $0.434 1 158 212
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT